108 related articles for article (PubMed ID: 25167942)
1. Helicobacter pylori and nonmalignant diseases.
Ierardi E; Goni E; Losurdo G; Di Mario F
Helicobacter; 2014 Sep; 19 Suppl 1():27-31. PubMed ID: 25167942
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori and nonmalignant diseases.
den Hollander WJ; Sostres C; Kuipers EJ; Lanas A
Helicobacter; 2013 Sep; 18 Suppl 1():24-7. PubMed ID: 24011241
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori and nonmalignant diseases.
Shmuely H; Katicic M; Filipec Kanizaj T; Niv Y
Helicobacter; 2012 Sep; 17 Suppl 1():22-5. PubMed ID: 22958151
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori and nonmalignant upper gastrointestinal diseases.
Jonaitis L; Pellicano R; Kupcinskas L
Helicobacter; 2018 Sep; 23 Suppl 1():e12522. PubMed ID: 30203583
[TBL] [Abstract][Full Text] [Related]
5. Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease.
McColl KE; Dickson A; El-Nujumi A; El-Omar E; Kelman A
Am J Gastroenterol; 2000 Jan; 95(1):101-5. PubMed ID: 10638566
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori and non-malignant diseases.
Furuta T; Delchier JC
Helicobacter; 2009 Sep; 14 Suppl 1():29-35. PubMed ID: 19712165
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori and non-malignant diseases.
Rokkas T; Simsek I; Ladas S
Helicobacter; 2007 Oct; 12 Suppl 1():20-2. PubMed ID: 17727456
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori and nonmalignant diseases.
Kuipers EJ; Malfertheiner P
Helicobacter; 2004; 9 Suppl 1():29-34. PubMed ID: 15347303
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori and Nonmalignant Diseases.
Potamitis GS; Axon AT
Helicobacter; 2015 Sep; 20 Suppl 1():26-9. PubMed ID: 26372821
[TBL] [Abstract][Full Text] [Related]
10. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
Peitz U; Raps S; Plein K; Leodolter A; Hotz Dagger J; Malfertheiner P
Dtsch Med Wochenschr; 2004 Mar; 129(13):671-5. PubMed ID: 15026962
[TBL] [Abstract][Full Text] [Related]
11. Should we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or low-dose aspirin?
Chan FK
Chin J Dig Dis; 2005; 6(1):1-5. PubMed ID: 15667550
[TBL] [Abstract][Full Text] [Related]
12. The influence of the eradication of Helicobacter pylori on gastric ghrelin, appetite, and body mass index in patients with peptic ulcer disease.
Jang EJ; Park SW; Park JS; Park SJ; Hahm KB; Paik SY; Sin MK; Lee ES; Oh SW; Park CY; Baik HW
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S278-85. PubMed ID: 19120912
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori and peptic ulcer disease. Current evidence for management strategies.
Chiba N; Lahaie R; Fedorak RN; Bailey R; Veldhuyzen van Zanten SJ; Bernucci B
Can Fam Physician; 1998 Jul; 44():1481-8. PubMed ID: 9678277
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori and nonmalignant diseases.
Alakkari A; Zullo A; O'Connor HJ
Helicobacter; 2011 Sep; 16 Suppl 1():33-7. PubMed ID: 21896083
[TBL] [Abstract][Full Text] [Related]
15. Dyspepsia and Helicobacter pylori.
Selgrad M; Kandulski A; Malfertheiner P
Dig Dis; 2008; 26(3):210-4. PubMed ID: 18463437
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori and non-steroidal anti-inflammatory drugs: does infection affect the outcome of NSAID therapy?
McCarthy DM
Yale J Biol Med; 1998; 71(2):101-11. PubMed ID: 10378355
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori and non-malignant diseases.
Shirin H; Leja M; Niv Y
Helicobacter; 2008 Oct; 13 Suppl 1():23-7. PubMed ID: 18783518
[TBL] [Abstract][Full Text] [Related]
18. The effect of a Helicobacter pylori treatment strategy on health care expenditures in patients with peptic ulcer disease and dyspepsia.
Kearney DJ; Liu CF; Crump C; Brousal A
Am J Gastroenterol; 2003 Sep; 98(9):1952-62. PubMed ID: 14499771
[TBL] [Abstract][Full Text] [Related]
19. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
Limmer S; Ittel TH; Wietholtz H
Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
[TBL] [Abstract][Full Text] [Related]
20. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
Brzozowski T; Konturek PC; Sliwowski Z; KwiecieĊ S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
